Pulmonary fibrosis modulation by mesenchymal stem cells and conditioned medium

R. Goncalves Felix (BOTUCATU, Brazil), A. Carvalho Bovolato (BOTUCATU, Brazil), P. Dos Santos Leão (RIBEIRÃO PRETO, Brazil), M. De Assis Golim (BOTUCATU, Brazil), W. Rosolia Teodoro (SÃO PAULO, Brazil), A. Todorovic Fabro (RIBEIRÃO PRETO, Brazil), E. Deffune (BOTUCATU, Brazil), V. Luiza Capelozzi (SÃO PAULO, Brazil)

Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Session: Translational aspects of idiopathic interstitial pneumonia
Session type: Thematic Poster
Number: 1284
Disease area: Interstitial lung diseases, Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Goncalves Felix (BOTUCATU, Brazil), A. Carvalho Bovolato (BOTUCATU, Brazil), P. Dos Santos Leão (RIBEIRÃO PRETO, Brazil), M. De Assis Golim (BOTUCATU, Brazil), W. Rosolia Teodoro (SÃO PAULO, Brazil), A. Todorovic Fabro (RIBEIRÃO PRETO, Brazil), E. Deffune (BOTUCATU, Brazil), V. Luiza Capelozzi (SÃO PAULO, Brazil). Pulmonary fibrosis modulation by mesenchymal stem cells and conditioned medium. 1284

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
PP206 – Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids
Source: ERS Lung Science Conference 2021
Year: 2021

Mesenchymal stem cells and conditioned medium in myofibroblast modulation and collagen production in vascular adventitia and parenchyma of experimental pulmonary fibrosis model
Source: International Congress 2016 – ILD pathogenesis
Year: 2016

Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020

LSC - 2021 - Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021


Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury
Source: Eur Respir J 2009; 34: 740
Year: 2009



Pulmonary interstitial glycogenosis cells express mesenchymal stem cell markers
Source: Eur Respir J, 56 (4) 2000853; 10.1183/13993003.00853-2020
Year: 2020



Pulmonary transplantation of human induced pluripotent stem cell-derived macrophages
Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside
Year: 2019


Epithelial stem cells at the intersection of tissue regeneration and pulmonary fibrosis
Source: Eur Respir Monogr 2021; 91: 290-305
Year: 2021


Mesenchymal stem cells isolated from fibrotic human lung tissue inhibit collagen expression by lung fibroblasts
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

PP238 – Role of mitochondrial function of lung mesenchymal stem cells in idiopathic pulmonary fibrosis
Source: ERS Lung Science Conference 2021
Year: 2021

Mechanical programming of mesenchymal stromal cells to treat lung fibrosis
Source: ERS Lung Science Conference 2018
Year: 2018

Protective roles of paracrine factors of bone marrow mesenchymal stem cells in bleomycin induced lung epithelial cell injury in vitro and pulmonary fibrosis in vivo
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010


Protective effect of mesenchymal stem cells (MSC) on hypoxia-induced epithelial-mesenchymal transition of alveolar epithelial cells (AEC)
Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond
Year: 2012

Electroporation of Hepatocyte growth factor to the lung induces migration of bone marrow mesenchymal stem cells and reduces lung fibrosis
Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Year: 2018


Increased TERT mRNA expression of bone marrow mesenchymal stem cells (BM-MSCs) in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010

Different effects of mesenchymal stem cells on elastase-induced pulmonary emphysema and macrophages activity in rats
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011


Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease
Source: Eur Respir Monogr 2021; 91: 205-221
Year: 2021


Expression of the biological axis VEGF-CXCL12/CXCR4 in bone marrow mesenchymal stem cells (BM MSCs) in patients with idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis
Year: 2008


Secreted mediators from induced pluripotent stem cells (iPSc) attenuate fibrosis in bleomycin injured rat lung
Source: Annual Congress 2012 - Stem cells and progenitors in injury and repair
Year: 2012